Abstract:Only a limited amount of orally administered lipid nanoparticles are absorbed as intact particles due to lipolysis by lipases in the gastrointestinal tract. It is hypothesized that by counteracting lipolysis, more particles will survive gastrointestinal digestion and be absorbed as intact particles. In this study, incorporation of a lipase inhibitor orlistat (OLST), as well as polyethylene glycol (PEG) coating, is employed to slow down the lipolysis using solid lipid nanoparticles (SLNs) as model particles. To explore the in vivo behaviors of the particles, near-infrared fluorescent probes with absolute aggregation-caused quenching (ACQ) properties are used to label and track the unmodified, PEG-coated and OLST-loaded SLNs. The in vitro lipolysis study indicates very fast first-order degradation of unmodified SLNs and significantly decreased degradation of OLST-SLNs. Live imaging reveals the same trend of slowed-down lipolysis in vivo which correlates well with the in vitro lipolysis. The scanning of ex vivo gastrointestinal segments confirms the considerably prolonged residence time of OLST-SLNs, mirroring the significantly decreased lipolysis rate. The observation of fluorescence in the blood, though very weak, and in the liver speaks of the oral absorption of intact SLNs. The substantially higher hepatic levels of OLST-SLNs than unmodified SLNs should be attributed to the significantly enhanced survival rate because both particles exhibit similar cellular recognition as well as similar physicochemical properties except for the survival rate. Similarly, slowing down lipolysis also contributes to the significantly enhanced cumulative lymphatic transport of OLST-SLNs (7.56% vs. 1.27% for the unmodified SLNs). The PEG coating slows down the lipolysis rate as well but not to the degree as done by OLST. As a result, the gastrointestinal residence time of PEG-SLNs has been moderately prolonged and the hepatic levels moderately increased. The weakened cellular recognition of PEG-SLNs implies that the enhanced oral absorption is solely ascribed to the slowed-down lipolysis and enhanced mucus penetration. In conclusion, the oral absorption of intact SLNs can be significantly enhanced by slowing down lipolysis, especially by OLST, showing potential as carriers for the oral delivery of labile biomacromolecules.

STEARIC ACID SOLID LIPID NANOPARTICLES SURFACE-MODIFIED WITH POLY (ETHYLENE GLYCOL): PREPARATION AND UPTAKE BY CELLS IN VITRO

Determination of surface properties and cell uptake in vitro of stearic acid solid lipid nanoparticles

[Uptake of Monostearin Solid Lipid Nanoparticles by A549 Cells].

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Effects of Degree of Substitution on Stearic Acid-Modified Bletilla Striata Polysaccharides Nanoparticles and Interactions Between Nanoparticles and Bovine Serum Albumin

Physical Characterization of Polyethylene Glycol Modified by Solid Lipid Nanoparticles for Targeted Drug Delivery

Studies on Oral Absorption of Stearic Acid SLN by a Novel Fluorometric Method

Improved Transport and Absorption Through Gastrointestinal Tract by PEGylated Solid Lipid Nanoparticles

Effect of the modification of ste aric acid solid lipid nanoparticles by chemical coating with Brij 78 on their body distribution in mice

Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.

Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.

Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system

Bile Salt/phospholipid Mixed Micelle Precursor Pellets Prepared by Fluid-Bed Coating

Preparation and characterization of self-aggregating micelles from stearic acid-modified burdock root polysaccharide

[Biodistribution and Hepatocytes Targeting of Cationic Liposomes Surface-Modified with Sterylglucoside and Golyethylene Glycol].

The Effect of PEGylation of Mesoporous Silica Nanoparticles on Nonspecific Binding of Serum Proteins and Cellular Responses

Carvacrol Loaded Solid Lipid Nanoparticles of Propylene Glycol Monopalmitate and Glyceryl Monostearate: Preparation, Characterization, and Synergistic Antimicrobial Activity

Coating function and stabilizing effects of surface layer protein from Lactobacillus acidophilus ATCC 4356 on liposomes

Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method

Studies on Insulin-Loaded Stearylamine Nanoparticles:Preparation and Physicochemical Properties

Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles